Aging Populations And Emerging Markets Will Drive Minimally Invasive Procedures
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
17 Aug 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
US$2.00
70.1% undervalued intrinsic discount21 Aug
US$0.60
1Y
-40.1%7D
-0.6%